» Articles » PMID: 18523723

Celecoxib As an in Vivo Probe of Cyclooxygenase-2 Mechanisms Underlying Retrograde Amnesia in an Animal Model of ECT

Overview
Specialties Neurology
Physiology
Date 2008 Jun 5
PMID 18523723
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cyclooxygenase-2 (COX-2) mechanisms are involved in glutamate-mediated learning and memory as well as in glutamatergic excitotoxicity. Electroconvulsive therapy (ECT)-induced amnesia may arise from glutamatergic excitotoxicity; if so, COX-2 inhibition may attenuate retrograde amnesia with ECT.

Methods: Wistar rats which received celecoxib (15 mg/kg per day) or vehicle for 18 days were trained for 3 days on a passive avoidance task. On each of the next 3 days, rats which showed perfect learning (n=51) received true or sham suprathreshold electroconvulsive shocks (ECS; 60 mC) in a factorial design; daily dosing with drug or vehicle was continued. One day after the last ECS, recall of pre-ECS learning was tested.

Results: ECS-treated rats showed impaired recall in the vehicle but not celecoxib group. Celecoxib significantly protected against ECS-induced retrograde amnesia; this benefit was independent of the drug-induced attenuation of ECS seizure duration.

Conclusions: Celecoxib may protect against ECS-induced retrograde amnesia by attenuating ECS-induced, COX-2-mediated glutamatergic excitotoxicity.

Citing Articles

Searching for the mechanism(s) of ECT's therapeutic effect.

McCall W, Andrade C, Sienaert P J ECT. 2014; 30(2):87-9.

PMID: 24755719 PMC: 4695970. DOI: 10.1097/YCT.0000000000000121.


Orchestrated regulation of Nogo receptors, LOTUS, AMPA receptors and BDNF in an ECT model suggests opening and closure of a window of synaptic plasticity.

Nordgren M, Karlsson T, Svensson M, Koczy J, Josephson A, Olson L PLoS One. 2013; 8(11):e78778.

PMID: 24244357 PMC: 3828303. DOI: 10.1371/journal.pone.0078778.


Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia.

Andrade C, Shaikh S, Narayan L, Blasey C, Belanoff J J Neural Transm (Vienna). 2011; 119(3):337-44.

PMID: 21922193 DOI: 10.1007/s00702-011-0712-8.


Molecular mechanisms underlying electroconvulsive therapy-induced amnestic deficits: A decade of research.

Andrade C Indian J Psychiatry. 2009; 50(4):244-52.

PMID: 19823608 PMC: 2755145. DOI: 10.4103/0019-5545.44745.


Continuing medical education.

Andrade C Indian J Psychiatry. 2009; 50(3):209-12.

PMID: 19742183 PMC: 2738364. DOI: 10.4103/0019-5545.43631.

References
1.
Stewart C, Jeffery K, Reid I . LTP-like synaptic efficacy changes following electroconvulsive stimulation. Neuroreport. 1994; 5(9):1041-4. DOI: 10.1097/00001756-199405000-00006. View

2.
Pigot M, Andrade C, Loo C . Pharmacological attenuation of electroconvulsive therapy--induced cognitive deficits: theoretical background and clinical findings. J ECT. 2008; 24(1):57-67. DOI: 10.1097/YCT.0b013e3181616c14. View

3.
Stecher J, Muller W, Hoyer S . Learning abilities depend on NMDA-receptor density in hippocampus in adult rats. J Neural Transm (Vienna). 1997; 104(2-3):281-9. DOI: 10.1007/BF01273188. View

4.
Warner T, Giuliano F, Vojnovic I, Bukasa A, Mitchell J, Vane J . Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999; 96(13):7563-8. PMC: 22126. DOI: 10.1073/pnas.96.13.7563. View

5.
Stewart C, Reid I . Electroconvulsive stimulation and synaptic plasticity in the rat. Brain Res. 1993; 620(1):139-41. DOI: 10.1016/0006-8993(93)90280-z. View